Lipids, Medications and Testing Archives - The Premiere Heart Health Education Platform

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

Should I take my cholesterol medicines? You bet.

Discover the comparative LDL-C lowering efficacy of statins, PCSK9 inhibitors, and bempedoic acid, alongside an evidence-based look at muscle safety and the nocebo effect.

August 2, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

ApoB: Longer, Higher, Worse

Is ApoB a better heart risk test than LDL? Standard tests measure cholesterol cargo, but ApoB counts the actual particles that block arteries. Learn why.

August 2, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

A disease you are born with

Is heart disease an inevitable part of aging? Discover how atherosclerosis begins before birth and why cumulative apoB exposure drives its lifelong progression.

August 2, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Can heart disease be reversed?

Is heart disease reversible? Discover the landmark primate studies proving how lipid lowering clears arterial foam cells and stabilizes advanced plaques.

July 18, 2026

ApoB and Lipid Science, Diet and Nutrition, Diet Comparisons, Lipids, Medications and Testing

Does metabolic health protect you from high cholesterol?

Is a zero-plaque heart scan on keto proof of safety? Discover how plaque latency explains a CAC of 0 despite extreme LDL, and why medical guidelines still urge caution.

July 17, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Can high cholesterol in your 20s and 30s cause a heart attack later even if you lower it?

Understand why ApoB is a more accurate predictor of heart disease than LDL, how "ApoB-years" build up over a lifetime, and how to lower your risk.

July 17, 2026

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Specific Foods

Are Seed Oils Healthy, True or False?

Examine the scientific evidence on seed oils versus olive oil. Learn how replacing saturated fats with plant oils lowers ApoB and cardiovascular risk.

July 10, 2026

Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal, Stents and Procedures

Treating the Biology, Not the Pipes: The Radical New Approach to Heart Disease

Imagine you are sitting in a small, sterile doctor’s office. The air is cool, the paper on the exam table crinkles under you, and your heart is thumping against your ribs—not from exercise, but from fear. Your doctor looks at a scan of your chest and says the words no one wants to hear: "You have a blockage."

July 7, 2026

Lipids, Medications and Testing, Medications and Treatments, Risk Screening, Risk, Genetics and Special Populations

Is your daily aspirin killing you or saving you? What the newest science says.

For many years, aspirin was seen as a "magic pill." People thought of it almost like a daily vitamin for the heart. It was very common for adults to start taking a baby aspirin every day "just in case." It seemed like a cheap and easy way to stop a heart attack or a stroke before it ever happened. Because aspirin is sold in every grocery store, it felt safe for everyone to use.

June 25, 2026

Genetics and Family Risk, Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations

Can Modern Medicine Save a Couch Potato? The 40-Year Triplet Experiment

Imagine you have a time machine. You travel back to the day three identical brothers turn 30 years old. They share the same DNA, the same upbringing, and the same healthy bodies. Because they are identical triplets, their baseline health markers are a perfect match: they all have a healthy weight, great insulin sensitivity, and excellent cardiorespiratory fitness. But on this day, they choose three very different paths for the next 40 years.

June 6, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Risk Screening, Risk, Genetics and Special Populations

Stop Trusting LDL! The Truth About ApoB, Insulin Resistance, & Diabetes

Imagine a man named Bob. Bob is 52 years old, slightly overweight, and has been told his blood sugar is a little high—what doctors call prediabetes. Bob is worried about his heart, so he goes to his doctor for a check-up. After a quick blood draw, the results come back. The doctor smiles and says, "Good news, Bob! Your LDL cholesterol is 90. That is a perfect score. You have nothing to worry about."

June 5, 2026

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

Ozempic and Mounjaro: Saving Your Heart BEFORE the Scale Moves

Imagine you just started a new medicine to help you lose weight. You are probably thinking about the numbers on your bathroom scale. You might be dreaming about fitting into your old favorite jeans or having more energy to play in the yard. But then, only a few weeks later, your doctor tells you something that stops you in your tracks. Even though you haven’t lost much weight yet, your heart is already much safer.

May 26, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Your Cells Make Their Own Cholesterol – So Why Is Your Blood Full Of It?

The average American adult carries about 5.6 grams of cholesterol circulating in plasma at any given moment — roughly the weight of a U.S. nickel. Careful mass-balance modeling of what lipoprotein particles need for structural integrity, plus what specialized tissues actually draw from the bloodstream each day, suggests the body's true circulating requirement is closer to 1.5 to 2.7 grams. The two- to four-fold surplus isn't toxic in itself.

May 19, 2026

ApoB and Lipid Science, Lipids, Medications and Testing

Why is ApoB important?

Imagine a man named John. John is 55 years old, active, and diligent about his health. He eats a Mediterranean diet and walks three miles every morning. At his last annual checkup, his doctor delivered what seemed like excellent news: his LDL cholesterol - the "bad" kind - was 80 mg/dL. In the world of standard medicine, that is a gold-star score. John felt invincible.

May 12, 2026

Lipids, Medications and Testing, Risk, Genetics and Special Populations, Special Populations

Testosterone Therapy and Your Heart: Why Your Total Score is Misleading

Imagine a man named Mark. Mark is 48 years old, and lately, he feels like a shell of his former self. Every day around 3:00 PM, he hits a "wall" of exhaustion that feels like swimming through deep mud. His "brain fog" makes it hard to focus at work, and he has completely lost the "spark" for his hobbies and his relationships. He is tired, moody, and just wants to nap.

May 8, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

The Million-Dollar Molecule: Why Your Body Pays a Fortune for Cholesterol

If your body were a blockbuster movie, cholesterol would be the character everyone loves to hate. We usually hear about it as the "villain" of the story—the bad guy responsible for heart trouble and clogged pipes. But if cholesterol is so truly "bad," why is it found in every single cell of your body? Why does your body work so hard to keep it around?

May 4, 2026

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

Children With 60-Year-Old Arteries: The Extreme Reality of HoFH

Imagine your body is a car, and your health is tracked by an odometer. For most of us, that odometer ticks up slowly and steadily. We might drive for 50 or 60 years before the engine starts to show significant wear and tear. But for some children, the odometer is spinning wildly out of control from the moment they are born. This is the reality of Homozygous Familial Hypercholesterolemia, or HoFH.

April 24, 2026

Imaging and Testing, Lipids, Medications and Testing, Risk Screening, Risk, Genetics and Special Populations

The Heart Health App That Finally Asks the Right Question

There are hundreds of heart health apps on the market today. Most of them do the same thing: they monitor your heart rate, track your steps, measure your sleep, and tell you to eat more vegetables. Some of the more sophisticated ones connect to wearables and give you a real-time readout of your pulse. A few will even flag an irregular heartbeat.

April 21, 2026

ApoB and Lipid Science, Diet and Nutrition, Diet Comparisons, Lipids, Medications and Testing

The Big Cholesterol Lie: Uncovering the Diet Industry’s Organized Denial

Imagine a doctor sitting in a dark room, peering through a powerful microscope at a tiny blob of yellow fat. For almost a hundred years, doctors looked at these blobs and thought they had found the "bad guy" causing heart disease. They called it cholesterol, and they believed that simply having too much of this "yellow grease" in your blood was the reason pipes in the body got clogged.

April 21, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Why Your ‘Normal’ Cholesterol is Actually a Warning Sign

For decades, we have been told that a "normal" cholesterol level is the golden ticket to a healthy heart. But modern science has revealed a startling truth: what we once called "normal" was never actually healthy. In the 1960s, a total cholesterol level of 240 mg/dL was considered a standard, acceptable baseline for an adult. Today, a doctor would view that same number as an urgent health crisis.

April 17, 2026

Imaging and Detection, Imaging and Testing, Lipids, Medications and Testing, Plaque, Arteries and Disease

The Heart Test Your Doctor Isn’t Ordering

A Coronary Artery Calcium (CAC) scan is a quick, painless CT scan — no dye required — that measures the amount of calcified, hardened plaque in the arteries around your heart. The result is your CAC score.

April 16, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Cholesterol: What Is It Good For?

For decades, we have been conditioned to view heart disease as a sudden catastrophe—a cardiac “lightning strike” that occurs in the sixth or seventh decade of life. In reality, atherosclerotic cardiovascular disease is a lifelong biological process, a silent passenger that boards the vessel in our youth. Despite mountains of “low-fat” dietary advice, heart disease remains the global leader in mortality.

April 7, 2026

ApoB and Lipid Science, Genetics and Family Risk, Lipids, Medications and Testing, Risk, Genetics and Special Populations

Can Good Genes Beat Bad Lipids?

Understanding Your Heart: High Cholesterol and Your Family History. The Big Picture: How Your Heart Stays Healthy. Think of your heart as the most important pump in your home, and your arteries as the "pipes" that carry life-sustaining blood to every room in your body. For the pump to work perfectly, those pipes need to stay clear and open.

March 30, 2026

ApoB and Lipid Science, Genetics and Family Risk, Lipids, Medications and Testing, Risk, Genetics and Special Populations

The Genetic Architecture of Cardiovascular Protection

Winning the Genetic Lottery: 3 Secrets Your DNA Reveals About a Healthy Heart. Introduction: The Mystery of the “Heart-Healthy” Gene. Why do some stay heart-healthy despite a poor diet? The answer lies in the “genetic lottery.” Scientists are decoding these mysteries using Mendelian randomization—the study of “experiments of nature.” These rare DNA variations act as natural off-switches, providing built-in shields against disease.

March 20, 2026

Inflammation Markers, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Which Came First – the Lipid or the Inflammation? Apolipoprotein B and the Chicken-and-Egg Problem of Atherogenesis

For decades, doctors and scientists have been locked in a "Chicken and Egg" mystery. When someone has a heart attack, their arteries are filled with two specific things: fatty buildup (lipids) and signs of a "swelling" immune response (inflammation).

March 14, 2026

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Specific Foods

The Myth of Coconut Oil as a Health Food: How Industry Influences What You Eat!

Coconut oil has been transformed from a traditional cooking fat into a modern “superfood,” marketed as a cure-all for weight loss, metabolism, thyroid health, and even heart protection. At the same time, the global coconut oil industry is booming, projected to reach well over $10 billion within the next decade.

March 3, 2026

Genetics and Family Risk, Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations

Double-Dosed: Is Your Family Tree a Bio-Hazard? Here’s the Life-Saving Information

We all inherit things from the people who came before us. You might have your grandmother’s bright blue eyes or your father’s booming, infectious laugh. These traits are like family heirlooms, passed down through the generations like a cherished watch or a secret recipe. But deep inside our cells, we also inherit "instruction manuals" called genes. Most of the time, these manuals work perfectly to keep us healthy. However, sometimes they contain tiny typos that can put our hearts in danger.

March 2, 2026

Lipids, Medications and Testing, Medications and Treatments, Plaque, Arteries and Disease, Regression and Reversal

The Cholesterol Breakthrough: From Daily Pills to Twice-a-Year Shots

Atherosclerotic cardiovascular disease (ASCVD) remains the leading global cause of mortality despite major advances in acute care. Modern preventive cardiology increasingly recognizes apolipoprotein B (ApoB)–containing lipoproteins as the necessary and causal drivers of atherosclerosis.

February 24, 2026

Imaging and Detection, Imaging and Testing, Lipids, Medications and Testing, Plaque, Arteries and Disease

Power of Zero: No Calcium – No Risk?

The clinical assessment of coronary artery calcium (CAC) has undergone a paradigm shift over the past three decades, evolving from a research tool to a central instrument in cardiovascular risk stratification.

February 22, 2026

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

Do Babies Need Statins?

For decades, the public has viewed heart disease as a “late-life accident”—a sudden collision of age and lifestyle that strikes in the golden years.

February 16, 2026

Imaging and Detection, Imaging and Testing, Lipids, Medications and Testing, Plaque, Arteries and Disease

A New Way of Looking Inside Your Heart Without Surgery – The Best Way to Predict a Heart Attack

Imagine you are driving your car down a long, quiet highway. You feel safe because you are looking at your dashboard. The gas tank is full, the engine temperature is fine, and no warning lights are blinking. To you, the car seems perfect. But deep inside the engine, out of sight, a tiny fuel line is leaking or a belt is starting to fray. You wouldn’t know there was a problem just by looking at the dashboard. You would only know if you pulled over, popped the hood, and had a mechanic look at the actual parts. The publication of the Bergström et al. study in the Journal of the American Medical Association (JAMA) on November 9, 2025, represents a landmark moment in the transition from population-based risk estimation to individualized, disease-based risk assessment.¹ This observational cohort study, conducted as part of the Swedish Cardiopulmonary Bioimage Study (SCAPIS), analyzed 24,791 individuals aged 50 to 64 years without established cardiovascular disease.

January 30, 2026

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Specific Foods

Heart Disease and Fish Oil

Have you ever stood in the supplement aisle at your local grocery store? It can be a very confusing place. There are hundreds of bottles of vitamins and oils. Many of them say "Fish Oil" in big, bright letters. Most of them have pictures of hearts or happy people. You might pick up a bottle and think you are buying a "magic shield" to protect your heart from getting sick. For decades, cardiovascular medicine has been dominated by a single, often misunderstood narrative: “Fish oil is good for your heart.” This belief has become so culturally entrenched that it blurs the line between evidence-based cardiology and retail wellness, leading millions of people to consume omega-3 supplements daily in the hope of reducing cardiovascular risk.

January 28, 2026

ApoB and Lipid Science, Imaging and Detection, Lipids, Medications and Testing, Plaque, Arteries and Disease

LDL “BAD” Cholesterol: Apolipoprotein B, Imaging Resolution, and the Illusion of “Normal” Coronary Arteries at Age 60

Imagine a man named John who just turned 60. John feels great. He goes for walks, eats his greens, and can still keep up with his grandkids. He recently went to his doctor for a big check-up. The doctor looked at his charts, checked his blood pressure, and gave him a "normal" report. His tests didn't show any big clogs, and his cholesterol numbers looked "fine." John left the office feeling like he had the heart of a teenager.

January 19, 2026

ApoB and Lipid Science, Exercise, Athletes and Aging, Lipids, Medications and Testing, Performance Science

Cholesterol for Athletes: How to Lower LDL Without Losing Your Edge (A Practical Guide to Statins)

If you’re an endurance athlete, you’ve probably had this moment: your fitness is undeniable—resting heart rate is low, VO₂ is high, your training log looks like a work of art—and then a blood test shows LDL (“bad cholesterol”) is higher than expected. That can feel unfair. It can also trigger a very specific fear: “If I take a statin, will I lose performance?”

January 19, 2026

Lipids, Medications and Testing, Medications and Treatments, Risk Screening, Risk, Genetics and Special Populations

The Future of Heart Disease Management

Imagine you are looking at a beautiful house. The lawn is a perfect green. The windows are clean and shiny. From the street, the house looks brand new. But behind the walls, there is a "ghost in the machine." The water pipes are old and rusty. The electric wires are fraying and sparking. You cannot see these problems just by looking at the outside. One day, a pipe bursts or a fire starts. Everyone is shocked. They say, "But the house looked so good!"

January 13, 2026

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Cholesterol: How Low is Too Low?

Can LDL Be Too Low? What PCSK9 Inhibitors Mean for Brain Health PCSK9 inhibitors are among the most powerful cholesterol-lowering treatments available. They can lower LDL (“bad cholesterol”) by 50–60% or more—and in some cases drive LDL below 20 mg/dL. That’s an incredible tool for preventing heart attacks and strokes. But it also raises a fair question: If the brain needs cholesterol, could LDL get “too low” and increase the risk of Alzheimer’s or dementia?

January 3, 2026

Inflammation Markers, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Integrative Dynamics of Apolipoprotein B, Lipoprotein(a), and C-Reactive Protein in Atherosclerotic Progression

Imagine a man named Sam. Sam is the kind of person we all want to be. He runs five miles every morning, he eats plenty of colorful vegetables, and he avoids junk food. When Sam went to his yearly check-up, his doctor had great news. The doctor looked at Sam’s blood test and said, "Your numbers are perfect! Your total cholesterol is low, and your LDL looks great. Your heart is in tip-top shape."

December 12, 2025

Inflammation Markers, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Inflammation, Lipoproteins, and the End of the LDL-Centric Era

For decades, preventive cardiology has been anchored by a single, powerful concept: the "lipid hypothesis." We operated under the assumption that cholesterol accumulation—specifically LDL-C—was the primary driver of atherosclerotic cardiovascular disease. The clinical directive was straightforward: push LDL-C down, and heart attack risk will follow. While this approach, largely driven by statin therapy, has undeniably saved millions of lives, we now know it is an incomplete strategy.

November 2, 2025

Lipids, Medications and Testing, Medications and Treatments, Plaque Biology, Plaque, Arteries and Disease

Nattokinase and Cardiovascular Plaque: What the Human Research Really Says

People want simple answers to complex problems. Atherosclerotic plaque—that fatty, inflammatory buildup inside artery walls—feels like something you should be able to “clean out” like a clogged pipe. That hope fuels massive interest in supplements that promise to “dissolve plaque,” “unclog arteries,” or “reverse heart disease naturally.”

October 10, 2025

ApoB and Lipid Science, Diet and Nutrition, Diet Comparisons, Lipids, Medications and Testing

The Protein Debate

Dr. Loren Cordain vs. Dr. T. Colin Campbell Original context: Public nutrition debate from the mid-2000s reflecting two competing paradigms: evolutionary biology versus whole-diet epidemiology. Participants and Context Verification

September 4, 2025

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Plant-Based Diets

The Plant-Based Paradox: Why Not All Veggie Diets Are Created Equal for Your Heart

For years, we've heard the chorus: "Eat more plants for a healthier heart!" And largely, that advice holds true. Numerous studies have championed the benefits of plant-forward eating patterns in reducing the risk of cardiovascular disease. But a recent study from the robust NutriNet-Santé cohort in France has introduced a crucial nuance, revealing that the type of plant-based diet matters — a lot. Simply going "plant-based" might not be enough if your plate is piled high with highly processed foods.

June 7, 2025

Inflammation, Lipids, Medications and Testing, Medications and Treatments, Plaque, Arteries and Disease

Can Decreasing Homocysteine with L-Methylfolate + Active B-Vitamins Help Prevent Atherosclerosis and Reduce Plaque?

Meet Sam. Sam is a person who cares deeply about staying healthy. Sam eats a big green salad every day and never touches greasy fast food. Sam walks three miles every afternoon, even when it is cold outside. When Sam goes to the doctor, the report looks pretty good. Sam’s cholesterol is in the safe zone. Sam’s blood pressure is not too high.

March 8, 2025

Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease, Stents and Procedures

The Ins and Outs of Cardiac Stents

The Facts Are cardiac stents necessary? The short answer: Yes, and no. Although this is a complicated question and the answer can be even more complicated, the most accurate and most straightforward solution is this: Yes if you are having a heart attack and No, for anything else.

August 13, 2019

💊

Research Hub

Lipids, Medications and Testing

Filter By Topic

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

ApoB and Lipid Science, Diet and Nutrition, Diet Comparisons, Lipids, Medications and Testing

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Specific Foods

Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal, Stents and Procedures

Lipids, Medications and Testing, Medications and Treatments, Risk Screening, Risk, Genetics and Special Populations

Genetics and Family Risk, Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations

ApoB and Lipid Science, Lipids, Medications and Testing, Risk Screening, Risk, Genetics and Special Populations

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

ApoB and Lipid Science, Lipids, Medications and Testing

Lipids, Medications and Testing, Risk, Genetics and Special Populations, Special Populations

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

Imaging and Testing, Lipids, Medications and Testing, Risk Screening, Risk, Genetics and Special Populations

ApoB and Lipid Science, Diet and Nutrition, Diet Comparisons, Lipids, Medications and Testing

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Imaging and Detection, Imaging and Testing, Lipids, Medications and Testing, Plaque, Arteries and Disease

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

ApoB and Lipid Science, Genetics and Family Risk, Lipids, Medications and Testing, Risk, Genetics and Special Populations

ApoB and Lipid Science, Genetics and Family Risk, Lipids, Medications and Testing, Risk, Genetics and Special Populations

Inflammation Markers, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Specific Foods

Genetics and Family Risk, Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations

Lipids, Medications and Testing, Medications and Treatments, Plaque, Arteries and Disease, Regression and Reversal

Imaging and Detection, Imaging and Testing, Lipids, Medications and Testing, Plaque, Arteries and Disease

Lipids, Medications and Testing, Medications and Treatments, Risk, Genetics and Special Populations, Special Populations

Imaging and Detection, Imaging and Testing, Lipids, Medications and Testing, Plaque, Arteries and Disease

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Specific Foods

ApoB and Lipid Science, Imaging and Detection, Lipids, Medications and Testing, Plaque, Arteries and Disease

ApoB and Lipid Science, Exercise, Athletes and Aging, Lipids, Medications and Testing, Performance Science

Lipids, Medications and Testing, Medications and Treatments, Risk Screening, Risk, Genetics and Special Populations

ApoB and Lipid Science, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Inflammation Markers, Lipids, Medications and Testing, Plaque, Arteries and Disease, Regression and Reversal

Inflammation Markers, Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease

Lipids, Medications and Testing, Medications and Treatments, Plaque Biology, Plaque, Arteries and Disease

ApoB and Lipid Science, Diet and Nutrition, Diet Comparisons, Lipids, Medications and Testing

ApoB and Lipid Science, Diet and Nutrition, Lipids, Medications and Testing, Plant-Based Diets

Inflammation, Lipids, Medications and Testing, Medications and Treatments, Plaque, Arteries and Disease

Lipids, Medications and Testing, Plaque Biology, Plaque, Arteries and Disease, Stents and Procedures

Heart Risk Calulator